Medicus Pharma Ltd WT (MDCXW)

$0.45 -0.15 (-24.94%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	N/A
Revenue (ttm)	0.00
Net Income (ttm)	0.00
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	N/A

Volume	17,047
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	Strong Buy
Price Target	N/A

Company Profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to M...

Phone: 610 540 7515

Website: medicuspharma.com

Address:

300 Conshohocken State Road, Suite 200, Conshohocken, United States